City

Bobigny (1)

Caen (1)

Lille (1)

Lyon (1)

Marseille (1)

Montpellier (1)

Reims (1)

Rouen (1)

St. Herblain (1)

Condition

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle (1)

Collaborator

Intervention

irinotecan monotherapy (1)

sorafenib and irinotecan combination (1)

sorafenib monotherapy (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

metastatic colorectal cancer patients with kras mutated tumors

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors Trial in France (Sorafenib and irinotecan combination, Sorafenib

Completed

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

Sorafenib and irinotecan combination
+2 more

Bobigny, France
+8 more

Aug 20, 2019